Ariosa Diagnostics Welcomes New Board Member Michael A. Aicher

        Ariosa Diagnostics Welcomes New Board Member Michael A. Aicher

PR Newswire

SAN JOSE, Calif., Feb. 25, 2013

SAN JOSE, Calif., Feb. 25, 2013 /PRNewswire/ --Ariosa Diagnostics, maker of
the non-invasive Harmony™ Prenatal Test for detection of common genetic
conditions, has announced the election of Michael A. Aicher to its Board of
Directors.

(Logo: http://photos.prnewswire.com/prnh/20130225/SF62999LOGO)

Mr. Aicher has had a very successful career in the molecular diagnostics
industry having spent the last 20 years in leadership positions at National
Genetics Institute (NGI), a wholly-owned subsidiary of Laboratory Corporation
of America® Holdings (LabCorp®), and LabCorp.

As the co-founder and CEO of NGI, Mr. Aicher steered the implementation of an
initial treatment model for HCV and secured the first FDA-approved HIV/HCV PCR
tests for plasma donor screening, with 15 million donations per year tested.
Under various leadership positions at LabCorp, he helped drive revenue and
margins within the esoteric testing business. Recognition for Mr. Aicher
includes distinction as an Ernst & Young "Entrepreneur of the Year" for
Emerging Technologies. Mr. Aicher recently took on the CEO position at Omicia,
a DNA sequencing informatics company.

"Ariosa Diagnostics is honored to welcome Michael Aicher to the board. His
multiple fields of expertise in strategy and operations within molecular
testing will greatly complement the existing board. We are pleased that he
will share his leadership and guidance with the team at Ariosa," said Ken
Song, MD, CEO of Ariosa.

About Ariosa Diagnostics

Ariosa Diagnostics, Inc. is a molecular diagnostics company committed to
innovating together to improve patient care. The flagship product, the Harmony
Prenatal Test, is a safe, highly accurate and affordable prenatal test for
maternal and fetal health. Led by an experienced team, Ariosa is using its
proprietary technology to perform a directed analysis of cell-free DNA in
blood. The Harmony Prenatal Test equips pregnant women and their healthcare
providers with reliable information to make decisions regarding their health,
without creating unnecessary stress or anxiety.

The company began operations in 2010 and is headquartered in San Jose, Calif.
For more information, visitwww.ariosadx.com. Follow us on Twitter
@HarmonyPrenatal and on Facebook at Harmony Prenatal for Healthy Pregnancy.

CONTACT:
Jen Bruursema
Ariosa Diagnostics
408-229-7539
jbruursema@ariosadx.com

SOURCE Ariosa Diagnostics

Website: http://www.ariosadx.com
 
Press spacebar to pause and continue. Press esc to stop.